Director, Redefining Early Stage Investment (Resi) Conference Series
Cambridge, Ma, Us
Responsible for the management and execution of the RESI Conference, a multimillion-dollar conference, five times a year with 600-1,000 attendees (investors and early-stage life science executives) per conference, 24 panels and workshops, 1,200 one-on-one meetings, 30-40 company presentations, 30 exhibitors. Lead cross-functional teams, establish, deliver, and implement growth strategies for expansion.• Develop and manage strategic partnerships with life science industry leaders, including Wuxi Apptec, Merck, Bayer, and Pfizer.• Manage event campaigns, vendor relationships, and logistics to expand company brand and achieve organizational goals.• Successfully authored and designed collateral material while building email campaigns to elevated brand engagement by 30%.• Oversees business development efforts for clients related to fundraising life science executives and investors, incubators, tech transfers, academic institutes, and top pharmaceutical companies in California and Oregon.• Conducts in-depth primary and secondary research, performed comprehensive competitive analysis, and accurately summarizes data, trends, and results for internal and external stakeholders.